<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NK cell genetic engineering &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/nk-cell-genetic-engineering/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:50:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>NK cell genetic engineering &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Innovative Tool Uncovers Key Targets to Enhance CAR NK Cell Therapy Effectiveness</title>
		<link>https://bioengineer.org/innovative-tool-uncovers-key-targets-to-enhance-car-nk-cell-therapy-effectiveness/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 22 Aug 2025 04:46:18 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer immunotherapy advancements]]></category>
		<category><![CDATA[CAR-NK cell therapy]]></category>
		<category><![CDATA[CRISPR screening platform]]></category>
		<category><![CDATA[NK cell genetic engineering]]></category>
		<category><![CDATA[Tumor microenvironment resistance]]></category>
		<guid isPermaLink="false">https://bioengineer.org/innovative-tool-uncovers-key-targets-to-enhance-car-nk-cell-therapy-effectiveness/</guid>

					<description><![CDATA[In a groundbreaking development that promises to reshape the landscape of cancer immunotherapy, scientists at The University of Texas MD Anderson Cancer Center have unveiled a revolutionary genome-wide CRISPR screening platform specifically designed for primary human natural killer (NK) cells. This innovative tool, dubbed PreCiSE, has empowered researchers to identify and target critical genetic regulators [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">256895</post-id>	</item>
	</channel>
</rss>
